alpha-cyano-4-hydroxycinnamate has been researched along with Osteosarcoma in 1 studies
alpha-cyano-4-hydroxycinnamate: specific inhibitor of pyruvate transport in rat liver mitochondria & human erythrocytes; structure
Osteosarcoma: A sarcoma originating in bone-forming cells, affecting the ends of long bones. It is the most common and most malignant of sarcomas of the bones, and occurs chiefly among 10- to 25-year-old youths. (From Stedman, 25th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhao, Z | 1 |
| Wu, MS | 1 |
| Zou, C | 1 |
| Tang, Q | 1 |
| Lu, J | 1 |
| Liu, D | 1 |
| Wu, Y | 1 |
| Yin, J | 1 |
| Xie, X | 1 |
| Shen, J | 1 |
| Kang, T | 1 |
| Wang, J | 1 |
1 other study available for alpha-cyano-4-hydroxycinnamate and Osteosarcoma
| Article | Year |
|---|---|
Downregulation of MCT1 inhibits tumor growth, metastasis and enhances chemotherapeutic efficacy in osteosarcoma through regulation of the NF-κB pathway.
Topics: Animals; Antineoplastic Agents; Bone Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; | 2014 |